Michael Henry, MD in Brighton, MA - Medicare Psychiatry

Michael Henry, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Brighton, Massachusetts. He went to University Of Massachusetts Medical School and graduated in 1987 and has 37 years of diverse experience with area of expertise as Psychiatry. He is a member of the group practice Massachusetts General Physicians Organization Inc, The General Hospital Corporation and his current practice location is 736 Cambridge St # Qn-3p, Brighton, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (617) 789-2623.

Michael Henry is licensed to practice in Massachusetts (license number 73484) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1346354222.

Contact Information

	Michael Henry, MD
	736 Cambridge St # Qn-3p, Brighton, MA 02135-2907
	(617) 789-2623
	(617) 562-5415

Physician's Profile

Full Name	Michael Henry
Gender	Male
Speciality	Psychiatry
Experience	37 Years
Location	736 Cambridge St # Qn-3p, Brighton, Massachusetts
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Michael Henry attended and graduated from University Of Massachusetts Medical School in 1987

NPI Data:

NPI Number: 1346354222
Provider Enumeration Date: 08/18/2006
Last Update Date: 02/15/2012

Medicare PECOS Information:

PECOS PAC ID: 5991744401
Enrollment ID: I20050425001034

Medical Identifiers

Medical identifiers for Michael Henry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1346354222	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	73484 (Massachusetts)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Massachusetts General Hospital	Boston, MA	Hospital
Newton-wellesley Hospital	Newton, MA	Hospital
Brigham And Women's Hospital	Boston, MA	Hospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael Henry allows following entities to bill medicare on his behalf.

Entity Name	Massachusetts General Physicians Organization Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434

News Archive

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure.

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Global leaders attending the US-hosted Global COVID-19 Summit on 22 September re-affirmed their commitment to ending the acute phase of the pandemic, and the goals of the ACT-Accelerator, by agreeing targets to provide equitable access to COVID-19 tests, treatments, and vaccines.

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

The recently FDA-authorized alpha-defensin lateral flow test is a highly accurate, ten-minute test for diagnosis of periprosthetic joint infection (PJI) - a serious and costly complication of total joint replacement, reports a study in The Journal of Bone & Joint Surgery.

Gene expression and lung cancer prognosis

While there have been significant advances in the use of gene expression profiling to assess a cancer prognosis, a Mayo Clinic review and analysis of existing lung cancer studies shows that this technology has not yet surpassed the accuracy of conventional methods used to assess survival in lung cancer patients.

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Arno Therapeutics, Inc., a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics, today announced that data from a preclinical study demonstrate its histone-deacetylase (HDAC) inhibitor AR-42 in combination with cisplatin has a synergistic anti-tumor effect in bladder cancer models.

Entity Name	The General Hospital Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

Gene expression and lung cancer prognosis

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Henry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael Henry, MD 77 Warren St, Brighton, MA 02135-3601 Ph: (617) 562-5485	Michael Henry, MD 736 Cambridge St # Qn-3p, Brighton, MA 02135-2907 Ph: (617) 789-2623

News Archive

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

Gene expression and lung cancer prognosis

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Psychiatry & Neurology Doctors in Brighton, MA

Monika Batra, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000
Karla Daniela Calzada Morales, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000
Dr. Joseph Michael Cocozzella, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Quinn Building 3rd Floor, Brighton, MA 02135 Phone: 617-789-2117
Thetsu Mon, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-2925
Jared Keith Trout, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-789-3000
Dr. Rania Mohammed Albesher, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Quinn Building, Brighton, MA 02135 Phone: 617-789-3000
Juan R Condemarin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 129 Bigelow St, Brighton, MA 02135 Phone: 617-254-4349

Michael Henry, MD - Medicare Psychiatry in Brighton, MA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Medicare Reassignments

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

Gene expression and lung cancer prognosis

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

Gene expression and lung cancer prognosis

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Lateral flow test enables faster, accurate diagnosis of periprosthetic joint infection

Gene expression and lung cancer prognosis

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Psychiatry & Neurology Doctors in Brighton, MA